Eko Foundation Analysis Software with Transformers (EFAST) vs VX1+
AI Verdict
Choose Eko Foundation Analysis Software with Transformers (EFAST) if…
Choose EFAST if your primary goal is to enhance routine cardiac screenings and facilitate early detection of structural murmurs and atrial fibrillation in a non-invasive setting. This tool is ideal for general clinicians and cardiologists seeking real-time, AI-powered insights during auscultation to quickly identify potential heart conditions and streamline patient referrals.
View Eko Foundation Analysis Software with Transformers (EFAST) →Choose VX1+ if…
Choose VX1+ if you are an electrophysiologist performing cardiac ablation procedures for atrial fibrillation or atrial tachycardia and require real-time, AI-driven assistance to identify abnormal electrograms. This software is specifically designed to integrate with existing EP lab systems, providing critical insights during invasive procedures to optimize ablation strategies.
View VX1+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Foundation Analysis Software with Transformers (EFAST) | VX1+ |
|---|---|---|
| Pricing | Subscription-based, contact for details | Unknown |
| Deployment | Unknown | Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Foundation Analysis Software with Transformers (EFAST)EFAST is designed for seamless integration into routine clinical workflows, offering real-time AI analysis during auscultation with enhanced audio and guided exams. Its focus on 'no additional steps' makes it broadly accessible for primary care and emergency settings. While VX1+ has a simple interface for its specialized use, EFAST's integration into a common, less invasive procedure provides broader usability.
Clinical Value
VX1+Both tools offer significant clinical value, but VX1+ stands out for its direct impact on complex, invasive procedures. It provides real-time AI guidance during cardiac ablation for AF and AT, standardizing a previously operator-dependent process and demonstrating high freedom from AF/AT in clinical outcomes. EFAST, while valuable for early detection in routine exams, addresses a broader diagnostic need rather than guiding a high-stakes interventional procedure.
Pricing & Value
Eko Foundation Analysis Software with Transformers (EFAST)Tool A (EFAST) offers greater transparency in its pricing model, outlining a subscription-based yearly membership and an approximate daily cost for its associated hardware. In contrast, Tool B (VX1+) provides no publicly available pricing information, making it impossible for potential customers to assess its value without direct contact.
Enterprise Readiness
Eko Foundation Analysis Software with Transformers (EFAST)EFAST demonstrates stronger enterprise readiness by explicitly stating FDA clearance, HIPAA compliance, and the availability of a Business Associate Agreement (BAA). Its cloud-based Software as a Medical Device (SaMD) deployment and EMR integration further streamline its adoption into existing healthcare IT infrastructures. While VX1+ is FDA-cleared and integrates with existing systems, explicit statements regarding BAA and HIPAA compliance are not provided in the facts.
Innovation
VX1+Both tools are highly innovative in their respective fields. However, VX1+ is recognized as the 'first FDA cleared AI-based tool in interventional cardiac electrophysiology,' providing real-time AI guidance during complex, invasive ablation procedures to standardize an operator-dependent process. This application of AI to directly guide a high-stakes interventional procedure represents a slightly higher bar for innovation in terms of complexity and direct impact on procedural outcomes.
Support & Docs
Eko Foundation Analysis Software with Transformers (EFAST)Eko Health provides comprehensive support for EFAST, including a dedicated Help Center with user manuals, email support via a contact form, scheduled phone calls, and options for live demos and Q&A sessions. While Volta Medical offers a user manual and contact information for VX1+, Eko Health's range of accessible support resources appears more extensive.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Foundation Analysis Software with Transformers (EFAST) | VX1+ |
|---|---|---|
| Name | Eko Foundation Analysis Software with Transformers (EFAST) | VX1+ |
| Primary Use Case | Assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation during routine exams. | Assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. |
| Company | Eko Health | Volta Medical |
| Key AI Functionality | AI-powered structural murmur detection (93% sensitivity, 91% specificity); AI-powered atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity); Real-time AI analysis during auscultation. | Real-time manual or automatic annotation of 3D anatomical and electrical maps; Identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures; AI-driven insights to assist electrophysiologists. |
| Target Medical Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and VX1+.
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Foundation Analysis Software with Transformers (EFAST) or VX1+
Backers
Who funded each tool's parent company.